copper gluconate has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flodh, H; Magnusson, G; Malmfors, T | 1 |
| Carter, RL; Mitchley, BC; Roe, FJ | 1 |
2 other study(ies) available for copper gluconate and EHS Tumor
| Article | Year |
|---|---|
Oncological study in rats of Ferastral, an iron-poly-(sorbitol-gluconic acid) complex, after intramuscular administration.
Topics: Animals; Carcinogens; Dose-Response Relationship, Drug; Drug Combinations; Female; Gluconates; Injections, Intramuscular; Iron; Iron-Dextran Complex; Male; Mice; Muscles; Neoplasm Metastasis; Sarcoma; Sarcoma, Experimental; Soft Tissue Neoplasms; Sorbitol | 1977 |
Induction of tumours in mice and rats with ferric sodium gluconate and iron dextran glycerol glycoside.
Topics: Animals; Fibroma; Gluconates; Glycosides; Injections, Subcutaneous; Iron; Iron-Dextran Complex; Male; Mice; Rats; Sarcoma, Experimental; Species Specificity | 1968 |